The Europe Coated Endotracheal Tube Market would witness market growth of 6.2% CAGR during the forecast period (2018 – 2024).
Endotracheal tube is a metal or plastic tube that is introduced in the trachea via the mouth or nose to validate the adequate exchange of oxygen and carbon dioxide and at the same time maintain the patient’s airway. Coated endotracheal tube is a specific tube coated with antithrombotic agents that is used to prevent coagulation or antibiotic agents such as polyvinyl chloride, silver, and various drugs to limit the growth of the bacteria on the surface of endotracheal tube. Growing number of surgical procedures due to increasing chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries are the factors that contribute to the growth of the market. Moreover, growing need for ventilator associated pneumonia and growth in geriatric population, that is highly prone to chronic diseases also significantly contribute to the market growth. However, post-operative complications related to endotracheal intubation and lack of skilled professionals are the factors that limit the market growth.
Based on End user, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on Intubation, the market is segmented into Orotracheal Intubation and Nasotracheal Intubation. Based on Application, the market is segmented into Anesthesia, Emergency Medicine and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sonoma Pharmaceuticals Inc., C. R. Bard, Inc., Hospiteknik Healthcare, Bactiguard Holding AB, Enox Biopharma Inc., Medline Industries, Inc., N8 Medical, LLC., Armstrong Medical, Teleflex Incorporated, Venner Medical GmbH.